| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/09/1999 | EP0921190A2 Frozen dough-resistant and high-sugar dough-resistant, practical baker's yeast |
| 06/09/1999 | EP0921189A1 Transgenic animal allergy models and methods for their use |
| 06/09/1999 | EP0921188A2 Genes encoding truncated cellulases and their use |
| 06/09/1999 | EP0921132A1 Novel human receptor type tyrosine kinase-like protein |
| 06/09/1999 | EP0920632A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 06/09/1999 | EP0920630A2 Prion protein binding proteins and uses thereof |
| 06/09/1999 | EP0920629A1 Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 06/09/1999 | EP0920626A1 Method for isolating a target biological material, capture phase, detecting phase and reagent containing them |
| 06/09/1999 | EP0920618A1 New kind of thin films for microsystem technology and microstructuring and their use |
| 06/09/1999 | EP0920538A1 Methods for diagnosing and assessing a predisposition to bipolar affective disorder |
| 06/09/1999 | EP0920537A1 Method for chromosomes classification |
| 06/09/1999 | EP0920536A1 Procedure for subtractive hybridization and difference analysis |
| 06/09/1999 | EP0920535A1 Method to detect clinically relevant mutations of the dna sequence of ki -ras oncogene, its use and a testkit for early diagnosis of tumours |
| 06/09/1999 | EP0920534A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA ($g(a)), HNF-1$g(b) AND HNF-4$g(a) |
| 06/09/1999 | EP0920533A2 Method for removing amplification inhibitors from test samples |
| 06/09/1999 | EP0920527A1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
| 06/09/1999 | EP0920526A1 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase |
| 06/09/1999 | EP0920525A1 TRANSFORMATION OF $i(PICHIA METHANOLICA) |
| 06/09/1999 | EP0920524A1 A short-shafted adenoviral fiber and its use |
| 06/09/1999 | EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 06/09/1999 | EP0920522A1 A vector for polynucleotide vaccines |
| 06/09/1999 | EP0920521A1 IDENTIFICATION OF AND CLONING A MOBILE TRANSPOSON FROM $i(ASPERGILLUS) |
| 06/09/1999 | EP0920520A2 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it, and method for weeding plants |
| 06/09/1999 | EP0920519A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 06/09/1999 | EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome |
| 06/09/1999 | EP0920517A1 Dna sequence useful for the production of polyhydroxyalkanoates |
| 06/09/1999 | EP0920516A2 Heat-stable dna polymerase of archaeobacteria of genus pyrococcus sp. |
| 06/09/1999 | EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 06/09/1999 | EP0920514A1 Targeting adenovirus with use of constrained peptide motifs |
| 06/09/1999 | EP0920513A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF MORAXELLA CATARRHALIS |
| 06/09/1999 | EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/09/1999 | EP0920511A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 06/09/1999 | EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS |
| 06/09/1999 | EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 06/09/1999 | EP0920508A1 HUMAN POLYHOMEOTIC 1 ($i(hph1)) ACTS AS AN ONCOGENE |
| 06/09/1999 | EP0920507A2 Secreted proteins and polynucleotides encoding them |
| 06/09/1999 | EP0920506A1 Human dbi/acbp-like protein |
| 06/09/1999 | EP0920505A1 Mammalian cell surface antigens; related reagents |
| 06/09/1999 | EP0920504A2 Voltage-gated calcium channel antagonist and methods |
| 06/09/1999 | EP0920503A2 A novel human leptin receptor gene-related protein |
| 06/09/1999 | EP0920502A1 Methods and means for modifying complement activation |
| 06/09/1999 | EP0920501A1 Neuritin, a neurogene |
| 06/09/1999 | EP0920500A1 Human proteolipid |
| 06/09/1999 | EP0920499A2 Polynucleotides encoding secreted proteins |
| 06/09/1999 | EP0920498A1 HAMSTER EF-1$g(a) TRANSCRIPTIONAL REGULATORY DNA |
| 06/09/1999 | EP0920497A1 Purification of plasmid dna by peg-precipitation and column chromatography |
| 06/09/1999 | EP0920496A1 Recombination of polynucleotide sequences using random or defined primers |
| 06/09/1999 | EP0920495A1 Transgenic animal model for alzheimer disease |
| 06/09/1999 | EP0920494A2 Pro-protein converting enzyme |
| 06/09/1999 | EP0920491A1 Immortalized cell lines for virus growth |
| 06/09/1999 | EP0920448A1 Truncated glial cell line-derived neurotrophic factor |
| 06/09/1999 | EP0920440A2 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 06/09/1999 | EP0920439A1 Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof |
| 06/09/1999 | EP0920339A2 Gene delivery system |
| 06/09/1999 | EP0920328A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
| 06/09/1999 | EP0920254A1 Programmed cell death and ich-3 |
| 06/09/1999 | EP0839045A4 Interleukin-1 receptor-associated protein kinase and assays |
| 06/09/1999 | EP0629242B1 Method for enhancing plant precocity and/or reducing the stored nitrate content of a plant |
| 06/09/1999 | EP0550687B1 5' to 3' exonuclease mutations of thermostable dna polymerases |
| 06/09/1999 | EP0282512B1 Messenger rna stabilization in animal cells |
| 06/09/1999 | CN1219330A Fixed wireless terminals in network management method and apparatus |
| 06/09/1999 | CN1219240A Purification of tissue plasminogen activator |
| 06/09/1999 | CN1219203A Process for the preparation of recombinant proteins in e. coli by high cell density fermentation |
| 06/09/1999 | CN1219202A Methods for producing and transforming cassave protoplasts |
| 06/09/1999 | CN1219201A Genetic constructs and method for producing fruits with very little or diminished seed |
| 06/09/1999 | CN1219200A Promoters of genes glutamate deshydrogenase, beta-N-acetylhexosaminidase and gamma actine, and their use in systems of expression, secretion and anti-sens in filamentary fungi |
| 06/09/1999 | CN1219199A Novel starches via modification of expression of starch biosynthetic enzyme genes |
| 06/09/1999 | CN1219198A Cultured inner cell mass cells derived from ungulate embryos |
| 06/09/1999 | CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 06/09/1999 | CN1218833A Polypeptide with cell withering promoting activity |
| 06/09/1999 | CN1218832A Thermal stable DNA polyase for detecting change of frequency |
| 06/09/1999 | CN1218813A Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 06/09/1999 | CN1218812A Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 06/09/1999 | CN1218691A Method for preparing oral medicine with silkworm expressed hepatitis C antigen |
| 06/09/1999 | CA2218199A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/08/1999 | US5910632 DNA encoding a pectin esterase, cells and plants derived therefrom |
| 06/08/1999 | US5910631 Middle chain-specific thioesterase genes from Cuphea lanceolata |
| 06/08/1999 | US5910630 Plant lysophosphatidic acid acyltransferases |
| 06/08/1999 | US5910629 Chimeric genes comprising a fungus-responsive element |
| 06/08/1999 | US5910628 Cap-independent translation sequences derived from barley yellow dwarf virus |
| 06/08/1999 | US5910627 Ph genes and their uses |
| 06/08/1999 | US5910626 Acetyl-CoA carboxylase compositions and methods of use |
| 06/08/1999 | US5910583 Antisense oligonucleotides against ERBB-2 |
| 06/08/1999 | US5910582 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 06/08/1999 | US5910581 Polypeptides of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptides |
| 06/08/1999 | US5910580 Streptococcus pneumoniae gene sequence HI1648 |
| 06/08/1999 | US5910576 Method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein |
| 06/08/1999 | US5910575 Monoclonal antibody which binds to (125)i-labeled derivatives of cortisol-3-carboxymethyloxime-histamine and preferentially binds to unlabeled syn isomer over unlabeled anti isomer; for competitive radioimmunoassay |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910573 Monomeric and dimeric antibody-fragment fusion proteins |
| 06/08/1999 | US5910572 Response regulator peptides; for screening bactericides |
| 06/08/1999 | US5910571 DNA encoding phage abortive infection protein from Lactococcus lactis and method of use thereof |
| 06/08/1999 | US5910488 Plasmids suitable for gene therapy |
| 06/08/1999 | US5910487 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/08/1999 | US5910483 Drug for treatment of growth related disorders, gastrointstinal tract diseases, anorexia nervosa and mammary cancer |
| 06/08/1999 | US5910481 Hybrid proteins with modified activity |
| 06/08/1999 | US5910480 (early placenta insulin-like peptide) molecule of the insulin family; induces dna synthesis, tyrosine phosphorylation |
| 06/08/1999 | US5910451 Trophinin and trophinin-assisting proteins |
| 06/08/1999 | US5910444 Plants in which the expression of S-adenosylhomocysteine hydrolase gene is inhibited |